Wnt pathway inhibition via the targeting of Frizzled receptors results in decreased growth and tumorigenicity of human tumors
Austin Gurney(Australian Centre for Heart Health), Timothy Hoey, John Lewicki(OncoMed (United States)), Wan-Ching Yen(OncoMed (United States)), Marcus Fischer(St. Jude Children's Research Hospital), Michelle Stroud(OncoMed (United States)), Jennifer Cain(Gilead Sciences (United States)), Aurélie Chaudhari(OncoMed (United States)), Fumiko Axelrod(OncoMed (United States)), Satyajit K. Mitra(Tampa Bay Research Institute), Christopher J. Bond, May Ji(OncoMed (United States)), Sanjeev Satyal(OncoMed (United States)), Ann M. Kapoun(OncoMed (United States)), Shirley Ma(University of Maryland Center for Environmental Science), Hoang Tran(OncoMed (United States)), Inkyung Park(Beltsville Agricultural Research Center), Sasha Lazetic(OncoMed (United States)), Kellie Pickell(OncoMed (United States)), Aaron K. Sato(OncoMed (United States)), Andrew Lam(OncoMed (United States)), Lucas Donigan(OncoMed (United States)), Cécile Chartier(Io Therapeutics (United States))
Cited by 630
Related Papers
Efficient generation of recombinant adenovirus vectors by homologous recombination in Escherichia coli
|Journal of Virology|1996|651
Colorectal Cancer Stem Cells Are Enriched in Xenogeneic Tumors Following Chemotherapy
|PLoS ONE|2008|582
Lifileucel, a Tumor-Infiltrating Lymphocyte Therapy, in Metastatic Melanoma
|Journal of Clinical Oncology|2021|431
IL-17E, a Novel Proinflammatory Ligand for the IL-17 Receptor Homolog IL-17Rh1
|Journal of Biological Chemistry|2001|410
Final results of the EORTC 18871/DKG 80-1 randomised phase III trial
|European Journal of Cancer|2003|240